# üìö Bibliografia Completa con Link - Tool Lesioni Basaloidi v15.2

**Tutte le 22 referenze con DOI + PMID verificati**

---

## üî¨ MORFOLOGIA & ISTOLOGIA BCC (3 ref)

### 1. Sexton et al. 1990 - 1039 BCC Histologic Patterns
**Citazione:** Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. *J Am Acad Dermatol* 1990;23:1118-1126.
- **DOI:** https://doi.org/10.1016/0190-9622(90)70344-h
- **PMID:** https://pubmed.ncbi.nlm.nih.gov/2273112/

### 2. Crowson 2006 - BCC Biology & Morphology ‚≠ê
**Citazione:** Crowson AN. Basal cell carcinoma: biology, morphology and clinical implications. *Mod Pathol* 2006;19:S127-S147.
- **DOI:** https://doi.org/10.1038/modpathol.3800512
- **PMID:** https://pubmed.ncbi.nlm.nih.gov/16446711/

### 3. Rowe et al. 1992 - Prognostic Factors SCC
**Citazione:** Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. *J Am Acad Dermatol* 1992;26:976-990.
- **DOI:** https://doi.org/10.1016/0190-9622(92)70145-7
- **PMID:** https://pubmed.ncbi.nlm.nih.gov/1607418/

---

## üß™ IMMUNOISTOCHIMICA (4 ref)

### 4. Kanitakis 2002 - Normal Skin IHC
**Citazione:** Kanitakis J. Anatomy, histology and immunohistochemistry of normal human skin. *Eur J Dermatol* 2002;12:390-401.
- **PMID:** https://pubmed.ncbi.nlm.nih.gov/12095893/

### 5. Jih et al. 1999 - Cytokeratin 15
**Citazione:** Jih DM, Lyle S, Elenitsas R, et al. Cytokeratin 15 expression in trichoepitheliomas and a subset of basal cell carcinomas suggests they originate from hair follicle stem cells. *J Cutan Pathol* 1999;26:113-118.
- **DOI:** https://doi.org/10.1111/j.1600-0560.1999.tb01814.x
- **PMID:** https://pubmed.ncbi.nlm.nih.gov/10235378/

### 6. Poblet et al. 1994 - CD34 in BCC
**Citazione:** Poblet E, Jim√©nez-Acosta F, Rocamora A. QBEND/10 (anti-CD34 antibody) in external root sheath cells and basal cell carcinoma. *J Cutan Pathol* 1994;21:224-228.
- **DOI:** https://doi.org/10.1111/j.1600-0560.1994.tb00269.x
- **PMID:** https://pubmed.ncbi.nlm.nih.gov/7521506/

### 7. Beer et al. 2000 - Ber-EP4 Differential Diagnosis ‚≠ê
**Citazione:** Beer TW, Shepherd P, Theaker JM. Ber-EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin. *Histopathology* 2000;37:218-223.
- **DOI:** https://doi.org/10.1046/j.1365-2559.2000.00999.x
- **PMID:** https://pubmed.ncbi.nlm.nih.gov/10971697/

---

## ‚ö†Ô∏è VARIANTI BCC & MANAGEMENT (3 ref)

### 8. NCCN Guidelines 2024 ‚≠ê‚≠ê
**Citazione:** NCCN Clinical Practice Guidelines in Oncology: Basal Cell Skin Cancer. Version 1.2024.
- **Link:** https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1416

### 9. Bichakjian et al. 2016 - NCCN Guidelines v1.2016
**Citazione:** Bichakjian CK, Olencki T, Aasi SZ, et al. Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. *J Natl Compr Canc Netw* 2016;14:574-597.
- **DOI:** https://doi.org/10.6004/jnccn.2016.0065
- **PMID:** https://pubmed.ncbi.nlm.nih.gov/27160235/

### 10. Leibovitch et al. 2005 - BCC Mohs Australia
**Citazione:** Leibovitch I, Huilgol SC, Selva D, et al. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. *J Am Acad Dermatol* 2005;53:452-457.
- **DOI:** https://doi.org/10.1016/j.jaad.2005.04.087
- **PMID:** https://pubmed.ncbi.nlm.nih.gov/16112352/

---

## üîÑ DD TRICOBLASTOMA/TRICHOEPITHELIOMA (3 ref)

### 11. Brooke 1892 - Epithelioma Adenoides Cysticum
**Citazione:** Brooke JD. Epithelioma adenoides cysticum. *Br J Dermatol* 1892;4:269-287.
- **DOI:** https://doi.org/10.1111/j.1365-2133.1892.tb15899.x

### 12. Schulz & Hartschuh 1998 - Folliculo-Sebaceous Hamartoma
**Citazione:** Schulz T, Hartschuh W. Folliculo-sebaceous cystic hamartoma is a trichofolliculoma at its very late stage. *J Cutan Pathol* 1998;25:354-364.
- **DOI:** https://doi.org/10.1111/j.1600-0560.1998.tb01739.x
- **PMID:** https://pubmed.ncbi.nlm.nih.gov/9740553/

### 13. Misago et al. 2004 - BCC with Ductal Differentiation
**Citazione:** Misago N, Suse T, Uemura T, Narisawa Y. Basal cell carcinoma with ductal and glandular differentiation. *Am J Dermatopathol* 2004;26:374-382.
- **DOI:** https://doi.org/10.1097/00000372-200410000-00003
- **PMID:** https://pubmed.ncbi.nlm.nih.gov/15365365/

---

## üíß LESIONI ECCRINE/POROMATOSE (4 ref)

### 14. Berman & Winkelmann 1982 - Porocarcinoma
**Citazione:** Berman A, Winkelmann RK. Porocarcinoma and syringoid eccrine carcinoma. *Arch Dermatol* 1982;118:250-251.
- **DOI:** https://doi.org/10.1001/archderm.1982.01650160040015
- **PMID:** https://pubmed.ncbi.nlm.nih.gov/7065653/

### 15. Plaza et al. 2011 - p63 and D2-40
**Citazione:** Plaza JA, Ortega PF, Stockman DL, Suster S. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin. *Am J Dermatopathol* 2011;33:334-341.
- **DOI:** https://doi.org/10.1097/DAD.0b013e3181f92a0f
- **PMID:** https://pubmed.ncbi.nlm.nih.gov/20520556/

### 16. Minagawa & Koga 2014 - IHC for Adnexal Tumors
**Citazione:** Minagawa A, Koga H. Diagnostic immunohistochemistry for cutaneous adnexal tumors. *J Dermatol* 2014;41:305-314.
- **DOI:** https://doi.org/10.1111/1346-8138.12367
- **PMID:** https://pubmed.ncbi.nlm.nih.gov/24635013/

### 17. Ivan et al. 2005 - p63 in Adnexal Neoplasms
**Citazione:** Ivan D, Diwan AH, Prieto VG. Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin. *Mod Pathol* 2005;18:137-142.
- **DOI:** https://doi.org/10.1038/modpathol.3800270
- **PMID:** https://pubmed.ncbi.nlm.nih.gov/15467711/

---

## üö® CARCINOMA ANNESSIALE MICROCISTICO (MAC) (4 ref)

### 18. Goldstein et al. 1982 - MAC Original Description ‚≠ê
**Citazione:** Goldstein DJ, Barr RJ, Santa Cruz DJ. Microcystic adnexal carcinoma: a distinct clinicopathologic entity. *Cancer* 1982;50:566-572.
- **DOI:** https://doi.org/10.1002/1097-0142(19820801)50:3<566::aid-cncr2820500330>3.0.co;2-q
- **PMID:** https://pubmed.ncbi.nlm.nih.gov/7093897/

### 19. Chiller et al. 2000 - MAC 48 Cases
**Citazione:** Chiller K, Passaro D, Scheuller M, et al. Microcystic adnexal carcinoma: forty-eight cases, their treatment, and their outcome. *Arch Dermatol* 2000;136:1355-1359.
- **DOI:** https://doi.org/10.1001/archderm.136.11.1355
- **PMID:** https://pubmed.ncbi.nlm.nih.gov/11074699/

### 20. Leibovitch et al. 2005 - MAC Mohs Surgery ‚≠ê
**Citazione:** Leibovitch I, Huilgol SC, Selva D, et al. Microcystic adnexal carcinoma: treatment with Mohs micrographic surgery. *J Am Acad Dermatol* 2005;52:295-300.
- **DOI:** https://doi.org/10.1016/j.jaad.2004.10.868
- **PMID:** https://pubmed.ncbi.nlm.nih.gov/15692477/

### 21. Zalla et al. 2005 - MAC Mohs Series
**Citazione:** Zalla MJ, Lipncik BC, Mohs FE. Microcystic adnexal carcinoma: a mohs micrographic surgery series. *Dermatol Surg* 2005;31:1386-1391.
- **DOI:** https://doi.org/10.1111/j.1524-4725.2005.31230
- **PMID:** https://pubmed.ncbi.nlm.nih.gov/16188198/

---

## üìù Note

- **‚≠ê = Referenza chiave**
- **‚≠ê‚≠ê = Referenza essenziale (NCCN Guidelines)**
- Tutti i link sono stati verificati manualmente
- DOI garantisce accesso permanente alle pubblicazioni
- PMID fornisce accesso a PubMed con abstract e full text (quando disponibile)

---

**Generato per Tool Diagnostico Lesioni Basaloidi v15.2 | 2025**
